FDA Inspection 1248362 — Vishal Bhupatbhai Sambada, MBBS, MD

Vishal Bhupatbhai Sambada, MBBS, MD — FEI 3030925801

The FDA completed an inspection of Vishal Bhupatbhai Sambada, MBBS, MD on Aug 23, 2024 in Ahmedabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 23, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ahmedabad (India)

Additional Details

Clinical BA/BE